Overview

A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

Status:
Completed

Trial end date:
2015-02-03

Target enrollment:

Participant gender:

Summary

The purpose of this study is to find out how much of Modigraf is absorbed and used in the body and how fast it leaves the body (Pharmacokinetics). The results will then help to decide how much Modigraf in future can be given safely to children and young people following transplantation.

Phase:

Phase 4

Details

Lead Sponsor:

Astellas Pharma Europe Ltd.

Treatments:

Tacrolimus